HEALTH AND ECONOMIC BURDEN OF INTERSTITIAL LUNG DISEASES
RESEARCHER PROFILE (Filmed April 2024)
Dr Ingrid Cox
Postdoctoral Research Fellow
Menzies Institute for Medical Research
University of Tasmania
Dr Ingrid Cox is a Postdoctoral Research Fellow at the Menzies Institute for Medical Research, University of Tasmania. She is a physician and health economist by training and has extensive experience working in healthcare, including in clinical practice, public health, health policy and health planning, and has worked with regional governmental agencies in the Caribbean and international development partners working in health.
Dr Cox’s main research interests focus on respiratory diseases and primarily on the economic burden and economic evaluation of interventions and treatments for their management. She earned her PhD from the University of Tasmania where her doctoral research examined the health and economic burden of idiopathic pulmonary fibrosis (IPF) in Australia, one component of the NHMRC Centre for Research Excellence for Pulmonary Fibrosis, a national project implemented alongside the Australian IPF Registry and the Lung Foundation Australia. This research provided the first epidemiological profile and first costing estimates of the economic burden of the disease in Australia, providing essential evidence for health service reimbursement policies.
Dr Cos completed her PhD in 2022 and since then has been the recipient of two Fellowships, the first the Menzies Postdoctoral Fellowship and the second a Fellowship with Lung Foundation Australia.
Currently Dr Cox’s research work spans several areas including her continued work on IPF and other interstitial lung diseases on several national projects, health services research including some work with the Royal Flying Doctor Service, prostate cancer research and her current lung cancer research funded by the major project grant of the Royal Hobart Hospital Research Foundation.
Dr Cox holds executive committee positions on the Australian Health Economics Society, the Professional Society or Health Economics and Outcomes Research both nationally and internationally, is currently the President of the Thoracic Society of Australia and New Zealand Tasmanian Branch and Chair of the Lung Cancer Special Interest Group.
Source: Supplied, Centre Of Research Excellence In Pulmonary Fibrosis
-
Dr Kelly-Anne Masterman
RESEARCH IN NEEDLE-FREE VACCINE DELIVERY SYSTEM
@ VAXXAS, BRISBANE, QUEENSLAND, AUSTRALIA -
Drug delivery of targeted therapies for pancreatic cancer, motor neurone disease
Associate Professor Kara Vine-Perrow is a cancer researcher, educator and research leader in the Faculty of Science, Medicine & Health at the University of Wollongong, where she serves as Deputy Director (Community Partnership and Impact) of the Molecular Horizons Research Institute and leads the Targeted Cancer Therapeutics Laboratory. Her research focuses on developing innovative drug delivery technologies, implantable medical devices and RNA-based therapeutics for difficult-to-treat diseases, with a particular emphasis on pancreatic cancer and motor neurone disease.
-
Pathogenicity, modelling & treatment of inherited retinal Stargardt disease
Dr Di Huang is a Research Associate at the Lions Eye Institute (LEI), working with A/Professor Fred Chen and Dr Sam McLenachan. Her research focuses on developing a robust platform of retinal pigment epithelium cells and retinal organoids derived from patient-specific induced pluripotent stem cells to model inherited retinal diseases, particularly Stargardt disease (STGD1).
